TY  - JOUR
AU  - Cheytan, Tasneem
AU  - Schneider, Martin
AU  - Würth, Roberto
AU  - Schwerd-Kleine, Paul
AU  - Gutjahr, Ewgenija
AU  - Thewes, Verena
AU  - Michel, Laura L
AU  - Weber, Rebecca
AU  - Vorberg, Tim
AU  - Lohr, Sabrina
AU  - Nitschke, Katja
AU  - Neßling, Michelle
AU  - Lichter, Peter
AU  - Schneeweiss, Andreas
AU  - Richter, Karsten
AU  - Helm, Dominic
AU  - Sprick, Martin
AU  - Trumpp, Andreas
TI  - Small extracellular vesicles and particles (sEVPs) derived from tumor-free pre-metastatic organs promote breast cancer metastasis and support organotropism.
JO  - Molecular cancer
VL  - 24
IS  - 1
SN  - 1476-4598
CY  - London
PB  - Biomed Central
M1  - DKFZ-2025-00516
SP  - 72
PY  - 2025
N1  - DKFZ-ZMBH Alliance  / #EA:A010#LA:A010#
AB  - Metastatic breast cancer remains largely incurable, partly due to our incomplete understanding of its intricate underlying mechanisms. Notably, intercellular communication mediated by small extracellular vesicles and particles (sEVPs) has emerged as a key feature of metastasis. While tumor-derived sEVPs have been extensively studied and are known to be pro-metastatic, the role of sEVPs from metastasis-prone normal tissue sites remains primarily undefined. Here, we characterized and studied the function of sEVPs secreted from tumor-free pre-metastatic organs (TuFMO-sEVPs) such as the brain and lungs in both immunocompetent and patient-derived xenograft models. TuFMO-sEVPs from the brain of mammary tumor-bearing mice were found to have a distinct protein content as compared to brain-sEVPs from tumor-free mice, suggesting that the primary tumor can systemically influence the cargo of TuFMO-sEVPs. Importantly, mice orthotopically injected with breast cancer cells which had been educated with either brain or lung TuFMO-sEVPs prior to transplantation showed significantly increased metastasis to the respective organ. We further demonstrated that TuFMO-sEVPs induced the expression of the enzyme dihydrofolate reductase (DHFR) upon uptake by breast cancer cells, leading to their enhanced metastatic capacity. Organ-specific signatures generated from TuFMO-sEVP educated tumor cells were found to be increased in metastatic samples from breast cancer patients as compared to the primary tumor or normal tissue samples and these signatures also significantly correlated with poorer patient outcome. Collectively, our data reveals a novel facet of the metastatic cascade, implicating a role for TuFMO-sEVPs in directing metastasis and providing a potential therapeutic strategy for targeting this process.
KW  - Animals
KW  - Humans
KW  - Female
KW  - Mice
KW  - Extracellular Vesicles: metabolism
KW  - Breast Neoplasms: pathology
KW  - Breast Neoplasms: metabolism
KW  - Cell Line, Tumor
KW  - Neoplasm Metastasis
KW  - Lung Neoplasms: metabolism
KW  - Lung Neoplasms: pathology
KW  - Lung Neoplasms: secondary
KW  - Xenograft Model Antitumor Assays
KW  - Brain metastasis (Other)
KW  - Breast cancer (Other)
KW  - Dihydrofolate reductase-mediated metastasis (Other)
KW  - Global proteomics analysis (Other)
KW  - Lung metastasis (Other)
KW  - Small extracellular vesicles and particles (sEVPs) (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:40057730
C2  - pmc:PMC11889877
DO  - DOI:10.1186/s12943-025-02235-8
UR  - https://inrepo02.dkfz.de/record/299575
ER  -